Randall Kaye, CMO at Longboard Pharmaceuticals, Inc. (LBPH), sold 33,434 shares at $34.55 ($1.2M) on 2024-08-12, disclosed to the SEC on 2024-08-13.
Scheduled sale ($1.2M) by CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.87 | 100 | $2K | 0.2% |
| 2 | $34.55 | 10,476 | $362K | 31.2% |
| 3 | $34.55 | 10,476 | $362K | 31.2% |
| 4 | $35.03 | 6,191 | $217K | 18.7% |
| 5 | $35.03 | 6,191 | $217K | 18.7% |
| Total | $34.69 avg | 33,434 |
| $1.2M |
| 100% |
| Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |
| AVNR | SELL | 2011-09-13 | $275K | — | Filing → |
| AVNR | SELL | 2011-01-07 | $41K | — | Filing → |